COLOMBATTI, RAFFAELLA
 Distribuzione geografica
Continente #
NA - Nord America 7.384
AS - Asia 5.199
EU - Europa 2.272
AF - Africa 982
SA - Sud America 944
OC - Oceania 94
Continente sconosciuto - Info sul continente non disponibili 46
Totale 16.921
Nazione #
US - Stati Uniti d'America 6.877
SG - Singapore 1.620
CN - Cina 796
VN - Vietnam 729
BR - Brasile 565
HK - Hong Kong 543
IT - Italia 394
DE - Germania 215
FR - Francia 205
FI - Finlandia 180
IN - India 170
PL - Polonia 157
BD - Bangladesh 136
TR - Turchia 95
GB - Regno Unito 94
IQ - Iraq 89
SE - Svezia 88
AR - Argentina 80
NL - Olanda 75
RU - Federazione Russa 75
PK - Pakistan 74
JP - Giappone 73
ZA - Sudafrica 63
AT - Austria 59
CA - Canada 56
PH - Filippine 53
SA - Arabia Saudita 50
UZ - Uzbekistan 50
CO - Colombia 49
MX - Messico 49
CI - Costa d'Avorio 47
ID - Indonesia 45
PY - Paraguay 45
UA - Ucraina 45
MA - Marocco 44
JO - Giordania 42
ES - Italia 41
IL - Israele 40
BJ - Benin 39
MY - Malesia 38
PE - Perù 38
EC - Ecuador 37
GH - Ghana 36
IR - Iran 36
LB - Libano 35
RO - Romania 35
VE - Venezuela 35
KG - Kirghizistan 34
IE - Irlanda 33
PT - Portogallo 33
TN - Tunisia 33
AE - Emirati Arabi Uniti 32
AO - Angola 32
EG - Egitto 32
NP - Nepal 32
RS - Serbia 32
AL - Albania 31
LC - Santa Lucia 31
BB - Barbados 30
CR - Costa Rica 29
DJ - Gibuti 29
KE - Kenya 29
LY - Libia 29
ML - Mali 29
PS - Palestinian Territory 29
GA - Gabon 28
GT - Guatemala 28
NO - Norvegia 28
PA - Panama 28
SK - Slovacchia (Repubblica Slovacca) 28
BE - Belgio 27
CL - Cile 27
GR - Grecia 27
HU - Ungheria 27
SN - Senegal 27
AZ - Azerbaigian 26
BG - Bulgaria 26
CM - Camerun 26
KR - Corea 26
MD - Moldavia 26
MK - Macedonia 26
MN - Mongolia 26
UY - Uruguay 26
CW - ???statistics.table.value.countryCode.CW??? 25
KH - Cambogia 25
SY - Repubblica araba siriana 25
TH - Thailandia 25
CU - Cuba 24
DK - Danimarca 24
HN - Honduras 24
KZ - Kazakistan 24
MZ - Mozambico 24
NG - Nigeria 24
NI - Nicaragua 24
TJ - Tagikistan 24
BZ - Belize 23
CY - Cipro 23
DZ - Algeria 23
ET - Etiopia 23
AU - Australia 22
Totale 15.885
Città #
San Jose 1.005
Singapore 994
Ashburn 929
Fairfield 741
Hong Kong 505
Woodbridge 459
Houston 361
Chandler 334
Seattle 279
Cambridge 250
Wilmington 239
Ho Chi Minh City 222
Beijing 178
Ann Arbor 176
Hanoi 164
Los Angeles 129
Boardman 127
Bytom 111
Santa Clara 104
Helsinki 103
Lauterbourg 91
New York 89
Princeton 85
Medford 69
Munich 69
San Diego 66
Council Bluffs 64
Jacksonville 64
Padova 57
São Paulo 51
Tokyo 51
Abidjan 47
Milan 47
Des Moines 46
Tashkent 44
Baghdad 42
Frankfurt am Main 41
Vienna 39
Buffalo 38
Chicago 38
Cotonou 37
Roxbury 37
Amman 36
Dong Ket 36
Da Nang 34
London 33
Orem 33
Bishkek 32
Castries 31
Hefei 31
Nuremberg 31
Dallas 30
Lahore 30
Bamako 29
Libreville 28
Turku 28
Bridgetown 27
Dakar 27
Djibouti 27
Panama City 27
Rome 27
Accra 26
Dublin 26
Luanda 26
San José 25
Ulan Bator 25
Baku 24
Guangzhou 24
Johannesburg 24
Lima 24
Managua 24
Montevideo 24
Dushanbe 23
Havana 23
Istanbul 23
Phnom Penh 23
Kampala 22
Nairobi 22
Cairo 21
Guatemala City 21
Harare 21
Riga 21
Vientiane 21
Willemstad 21
Casablanca 20
Redondo Beach 20
Brooklyn 19
Noumea 19
Warsaw 19
Maputo 18
Nanjing 18
Reykjavik 18
Rio de Janeiro 18
Tripoli 18
Addis Ababa 17
Belgrade 17
Brussels 17
Chisinau 17
Nouakchott 17
Podgorica 17
Totale 10.022
Nome #
Treosulfan-based conditioning regimen in sibling and alternative donor hematopoietic stem cell transplantation for children with sickle cell disease 317
Spleen histology in children with sickle cell disease and hereditary spherocytosis: Hints on the disease pathophysiology 288
Coagulation Activation in Children with Sickle Cell Disease Is Associated with Cerebral Small Vessel Vasculopathy 273
Evaluation of Technical Issues in a Pilot Multicenter Newborn Screening Program for Sickle Cell Disease 251
Results of a multicenter universal newborn screening program for sickle cell disease in Italy: A call to action 249
Haploidentical stem cell transplantation cures autoimmune hepatitis and cerebrovascular disease in a patient with sickle cell disease 234
Early-onset indicators of a hypercoagulable state and clinical complications in a cohort of children with sickle cell trait 230
Intellectual impairment and TCD evaluation in children with sickle cell disease and silent stroke 227
Cognitive evoked potentials and neural networks are abnormal in children with sickle cell disease and not related to the degree of anaemia, pain and silent infarcts 222
Pulmonary hypertension in sickle cell disease children under 10 years of age 221
Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference 221
Posterior cerebral circulation in children with sickle cell anemia: an uncharted territory 216
A study of the geographic distribution and associated risk factors of leg ulcers within an international cohort of sickle cell disease patients: the CASiRe group analysis 214
An Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research 209
Hospitalization of children with sickle cell disease in a region with increasing immigration rates. 206
Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey 205
Residual Cerebrovascular Morbidity Despite Treatment in Pediatric Sickle Cell Disease Highlights Opportunities for Earlier, Intensified Monitoring and Treatment 203
Selective Difficulties in Lexical Retrieval and Nonverbal Executive Functioning in Children With HbSS Sickle Cell Disease 203
Transcranial Doppler Sonography in children with sickle cell disease and silent ischemic lesions 202
Tricuspid regurgitant velocity elevation in a three-year old child with sickle cell anemia and recurrent acute chest syndromes reversed not by hydroxyurea but by bone marrow transplantation 201
primary stroke prevention for sickle cell disease in north-east Italy: the role of ethnic issues in establishing a Transcranial Doppler screening program 200
Airways obstruction and pulmonary capillary blood volume in children with sickle cell disease 198
Lipoarabinomannan antigenic epitope differences in tuberculosis disease subtypes 197
Acute Chest Syndrome in Children with Sickle Cell Disease in Italy: Results of a National Survey from the Italian Association of Pediatric Hematology Oncology (AIEOP) 194
Pediatric Moyamoya Disease and Syndrome in Italy: A Multicenter Cohort 191
Relationship between hemoglobin, hemolysis, and transcranial Doppler velocities in children with sickle cell disease: Results from a long-term natural history study in Italy in the era of multimodal therapy 189
Malaria prevention reduces in-hospital mortality among severely ill tuberculosis patients: a three-step intervention in Bissau, Guinea-Bissau. 188
Comprehensive care for sickle cell disease immigrant patients: A reproducible model achieving high adherence to minimum standards of care. 184
European Intergroup Studies (MMT4-89 and MMT4-91) on Childhood Metastatic Rhabdomyosarcoma: Final Results and Analysis of Prognostic Factors 183
An Educational Study Promoting the Delivery of Transcranial Doppler Ultrasound Screening in Paediatric Sickle Cell Disease: A European Multi-Centre Perspective 182
A multinational trial of prasugrel for sickle cell vaso-occlusive events 180
CK2β Regulates Hematopoietic Stem Cell Biology and Erythropoiesis 178
Distribution of HbS Allele and Haplotypes in a Multi-Ethnic Population of Guinea Bissau, West Africa: Implications for Public Health Screening 176
Association between a combination of single nucleotide polymorphisms and large vessel cerebral vasculopathy in African children with sickle cell disease 175
Childhood sickle cell disease in north-east Italy: genetic, hematologic, clinical characteristics and social challenges of an emerging disease: a single center experience 174
INTENSIVE CHEMOTHERAPY FOR CHILDREN AND YOUNG ADULTS WITH METASTATIC NEUROECTODERMAL TUMORS OF THE SOFT TISSUE 172
Direct detection by the xpert MTB/RIF assay and characterization of multi and poly drug- resistant tuberculosis in Guinea-Bissau, West Africa 170
High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma 169
Limited access to transcranial Doppler screening and stroke prevention for children with sickle cell disease in Europe: Results of a multinational EuroBloodNet survey 168
Prevention of neurovascular complications in children with Sickle Cell Disease in the real-world setting: What adult medicine physicians should know 166
Microvasculopathy and biomarkers in sickle cell disease: the promise of non-invasive real-time in vivo tools 162
Cognition and the default mode network in children with sickle cell disease: A resting state functional MRI study 159
Hematological characteristics and hepatobiliary complications of hereditary spherocytosis in a tertiary care pediatric center: optimizing diagnosis and care through local and international networks 156
HbS/β+ thalassemia: Really a mild disease? A National survey from the AIEOP Sickle Cell Disease Study Group with genotype-phenotype correlation 155
Monitoring oral iron therapy in children with iron deficiency anemia: an observational, prospective, multicenter study of AIEOP patients (Associazione Italiana Emato-Oncologia Pediatrica) 154
Impact of sickle cell disease on patients' daily lives, symptoms reported, and disease management strategies: Results from the international Sickle Cell World Assessment Survey (SWAY) 151
Global geographic differences in healthcare utilization for sickle cell disease pain crises in the CASiRe cohort 151
Intellectual function evaluation of first generation immigrant children with sickle cell disease: the role of language and sociodemographic factors 150
Longitudinal evaluation of cerebral white matter hyperintensities lesion volume in children with sickle cell disease 150
Severe hemolytic anemia in a newborn: Look out for rare Gardos channelopathies due to KCNN4 mutation 149
Point-of-care testing allows successful simultaneous screening of sickle cell disease, HIV, and tuberculosis for households in rural Guinea-Bissau, West Africa 149
Visual cortex changes in children with sickle cell disease and normal visual acuity: a multimodal magnetic resonance imaging study 148
Feasibility and effectiveness of tuberculosis active case-finding among children living with tuberculosis relatives: A cross-sectional study in Guinea-Bissau 148
THE ROLE OF EXECUTIVE DYSFUNCTIONS IN THE VERBAL LANGUAGE DEFICITS OF CHILDREN WITH SICKLE CELL DISEASE 145
A short-term intervention for the treatment of severe malnutrition in a post-conflict country: Results of a survey in Guinea Bissau 143
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission 142
Safety and efficacy of mitapivat in sickle cell disease (RISE UP): results from the phase 2 portion of a global, double-blind, randomised, placebo-controlled trial 142
Organizing national responses for rare blood disorders: The Italian experience with sickle cell disease in childhood 140
Anemia and transfusion in the neonate 139
Lessons learned from the H1N1 pandemic: The need to improve systematic vaccination in Sickle Cell Disease children. A multi center survey in Italy 138
Are we ready for new strategies to prevent stroke in children with sickle cell disease? 137
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience 137
Newborn screening for sickle cell disease in Europe 133
Acute chest syndrome in children with sickle cell disease: Data from a national AIEOP cohort identify priority areas of intervention in a hub-and-spoke system 132
The Guinea-Bissau Family of Mycobacterium tuberculosis Complex Revisited 132
Annual Academy of Sickle Cell and Thalassaemia (ASCAT) conference: a summary of the proceedings 132
Age of first pain crisis and associated complications in the CASiRe international sickle cell disease cohort 131
Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet 129
Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned 129
ENERCA clinical recommendations for disease management and prevention of complications of sickle cell disease in children 129
The Management of Sickle Cell Pain in the Emergency Department: A Priority For Health Systems. 124
Real-Life experience with hydroxyurea in patients with sickle cell disease: Results from the prospective ESCORT-HU cohort study 123
Short term advantages of a public-private partnership for tuberculosis in Guinea Bissau: Reduction of mortality and increased diagnostic capacity 118
Recombinant erythropoietin vs. blood transfusion care in infants with hereditary spherocytosis: a retrospective cohort study of A.I.E.O.P. patients (Associazione Italiana Emato-Oncologia Pediatrica) 116
Transfusional Approach in Multi-Ethnic Sickle Cell Patients: Real-World Practice Data From a Multicenter Survey in Italy 114
Sickle cell disease landscape and challenges in the EU: the ERN-EuroBloodNet perspective 114
Early splenectomy in sickle cell disease: another piece of the puzzle 114
Intracranial circulation in sickle cell disease 114
Thrombocytopenia and splenomegaly: An unusual presentation of congenital hepatic fibrosis 113
American Society of Hematology 2020 Podcast Collection: Sickle Cell Anaemia 113
Novel findings from the multinational DOVE study on geographic and age-related differences in pain perception and analgesic usage in children with sickle cell anaemia 112
Treatment of dental and orthodontic complications in thalassaemia 111
Disease burden and quality of life of in children with sickle cell disease in Italy: time to be considered a priority 111
Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study 110
null 109
Environmental Factors in Northern Italy and Sickle Cell Disease Acute Complications: A Multicentric Study 107
Editorial for special issue “newborn screening for sickle cell disease and other haemoglobinopathies” 106
Systematic Literature Review Shows Gaps in Data on Global Prevalence and Birth Prevalence of Sickle Cell Disease and Sickle Cell Trait: Call for Action to Scale Up and Harmonize Data Collection 105
Paediatric Emergency Department use and risk factors for admission in Sickle Cell Disease Children in a country without comprehensive care 105
Sickle cell disease: embedding patient participation into an international conference can transform the role of lived experience 104
Erythrocyte microRNAs: a tiny magic bullet with great potential for sickle cell disease therapy 104
Successful Treatment of Severe Iatrogenic Calcinosis Cutis with Intravenous Sodium Thiosulfate in a Child Affected by T-Acute Lymphoblastic Leukemia 99
Complicanze acute dell’anemia falciforme nel bambino: progressi nell’ottimizzazione delle cure ed aree suscettibili di miglioramento nell’esperienza del Pronto Soccorso Pediatrico di Padova 97
Dalla Guinea Bissau a Padova per l’alta specializzazione:un nuovo modello per la globalozzazione della Pediatria? 97
European migration crises: The role of national hemoglobinopathy registries in improving patient access to care 96
Pain Frequency and Health Care Utilization Patterns in Women with Sickle Cell Disease Experiencing Menstruation-Associated Pain Crises 95
Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato‐Oncologia Pediatrica) study group 95
Health-related quality of life in hemoglobinopathies: A systematic review from a global perspective 94
Contamination of drinking water sources during the rainy season in an urban post-conflict community in Guinea Bissau: implications for sanitation priority 94
Problematiche acute dell’Anemia Falciforme nel bambino: esperienza del Pronto Soccorso Pediatrico di Padova 90
Totale 15.722
Categoria #
all - tutte 48.944
article - articoli 48.542
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021179 0 0 0 0 0 0 0 0 0 0 60 119
2021/2022942 22 37 102 63 79 81 25 149 69 29 77 209
2022/2023663 177 73 13 73 83 56 5 48 74 2 54 5
2023/2024438 20 54 47 32 25 43 25 37 21 13 47 74
2024/20252.248 7 178 103 68 253 36 79 192 254 98 406 574
2025/202610.211 496 788 1.528 1.666 825 437 1.179 1.004 1.064 657 567 0
Totale 17.053